DFDA

Low FODMAP Diet

Treatment for Irritable Bowel Syndrome

Typical Dosage: Adherence to dietary guidelines, often with dietitian guidance

Effectiveness
75%
Safety Score
90%
Clinical Trials
78
Participants
5K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
90
DangerousModerateSafe
Treatment Details
Dosage Range
Adherence to dietary guidelines, often with dietitian guidance
Time to Effect
1-4 weeks
Treatment Duration
Initial elimination (2-6 weeks), reintroduction (6-8 weeks), personalized long-term
Evidence Quality
MODERATE
Number Needed to Treat (NNT)
3(Treat 3 patients to see 1 additional successful outcome)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$800
Side Effect Mgmt:$0
Total Annual:$800
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$10,000/QALY
QALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$1,667
Cost per Remission
$2,857
Comparison vs Standard IBS care (e.g., lifestyle advice, antispasmodics)
Cost Difference
+$500/year
More expensive
QALY Difference
+0.15 QALYs
Better outcomes
Dominance
No dominance
Low FODMAP Diet Outcomes

for Irritable Bowel Syndrome

Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+60%
Remission Rate
+35%
Common Side Effects
Dietary restriction challenges
+40%
Potential impact on gut microbiome
+20%
Nutritional inadequacy (if poorly managed)
+10%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
5 active trials recruiting for Low FODMAP Diet in Irritable Bowel Syndrome

Effect of a Low FODMAP Diet in IBS and Functional Constipation with Bloating: a Randomized Double-Blind Trial

NCT06871748NOT YET RECRUITINGNA
View Study
34 participants
INTERVENTIONAL
Started: Mar 15, 2025

The Stool Microbiome of Treated and Untreated IBS (Irritable Bowel Syndrome) Patients

NCT05972317RECRUITINGNA
View Study
100 participants
INTERVENTIONAL
Rehovot, Israel
Started: May 11, 2026

Efficacy of a Low FODMAP Diet in the Absence of Lactose Malabsorption in Moderate to Severe ROME IV IBS.

NCT05120752RECRUITINGPHASE3
View Study
60 participants
INTERVENTIONAL
Jette, Belgium
Started: Nov 2, 2021

Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation

NCT03687814RECRUITINGNA
View Study
78 participants
INTERVENTIONAL
Ann Arbor, United States
Started: Nov 8, 2018

Efficacy of the DOMINO Diet App in IBS

NCT05808036RECRUITINGNA
View Study
110 participants
INTERVENTIONAL
Leuven, Belgium
Started: Apr 1, 2023
Completed Clinical Trials
9 completed trials for Low FODMAP Diet in Irritable Bowel Syndrome

Effects of Low FODMAP Diet on Leaky Gut

NCT04526808COMPLETEDNA
View Study
14 participants
INTERVENTIONAL
Boston, United States +1 more
Started: May 20, 2019

Online Low-FODMAP Diet in Irritable Bowel Syndrome

NCT07172581COMPLETEDNA
View Study
40 participants
INTERVENTIONAL
Montreal, Canada
Started: May 23, 2020

Low-FODMAP vs Gluten-Free Diet in Irritable Bowel Syndrome

NCT07800650COMPLETEDNA
View Study
70 participants
INTERVENTIONAL
Erzurum, Turkey (Türkiye)
Started: Dec 24, 2025

Low-FODMAP vs Lactose-Gluten-Free Diet in Patients With Irritable Bowel Syndrome

NCT07722572COMPLETEDNA
View Study
72 participants
INTERVENTIONAL
Istanbul, Turkey (Türkiye)
Started: Sep 1, 2020

Carbohydrate Reduction and Impact on Gastrointestinal System

NCT03729622COMPLETEDNA
View Study
65 participants
INTERVENTIONAL
Nottingham, United Kingdom
Started: Jan 1, 2016

The Effect of the Low FODMAP Diet and Dietary Oligofructose on Gastrointestinal Form, Function and Microbiota

NCT02259465COMPLETEDNA
View Study
45 participants
INTERVENTIONAL
Nottingham, United Kingdom
Started: Sep 1, 2014

EFFECT OF A DİETİTİAN-SUPERVİSED LOW-FODMAP DİET VERSUS STANDARD WRİTTEN ADVİCE ON GASTROİNTESTİNAL SYMPTOMS AND INFLAMMATORY BİOMARKERS İN IRRİTABLE BOWEL SYNDROME: A RANDOMİZED CONTROLLED TRİAL

NCT07619573COMPLETEDNA
View Study
50 participants
INTERVENTIONAL
Istanbul, Turkey (Türkiye) +1 more
Started: Apr 1, 2025

Effects of Low FODMAP Diet on Colonic Epithelial Physiology in Diarrhea-predominant Irritable Bowel Syndrome

NCT04542018COMPLETEDNA
View Study
48 participants
INTERVENTIONAL
Boston, United States +1 more
Started: Aug 3, 2020

The Effects of FODMAPs in Patients With Irritable Bowel Syndrome

NCT05182593COMPLETEDNA
View Study
30 participants
INTERVENTIONAL
Gothenburg, Sweden
Started: Feb 1, 2019
Showing 20 of 89 total trials